17:05 EDT Tonix Pharmaceuticals files $300M mixed securities shelf
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TNXP:
- Tonix Pharma Secures Patent, Eyes Migraine Market Growth
- Tonix Pharmaceuticals announces issuance of U.S. patent on Tosymra
- Tonix Pharmaceuticals Announces Issuance of U.S. Patent by the United States Patent and Trademark Office Covering the Intranasal Delivery of FDA-Approved Tosymra® to Treat Migraines
- Tonix Pharma Advances Promising Mpox Vaccine Candidate
- Tonix announces single dose of TNX-801 aligns with WHO Preferred TPP